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ABSTRACT The COVID-19 pandemic has triggered an urgent call to contribute to the fight against
an immense threat to the human population. Computer Vision, as a subfield of artificial intelligence, has
enjoyed recent success in solving various complex problems in health care and has the potential to contribute
to the fight of controlling COVID-19. In response to this call, computer vision researchers are putting
their knowledge base at test to devise effective ways to counter COVID-19 challenge and serve the global
community. New contributions are being shared with every passing day. It motivated us to review the recent
work, collect information about available research resources, and an indication of future research directions.
We want to make it possible for computer vision researchers to find existing and future research directions.
This survey paper presents a preliminary review of the literature on research community efforts against
COVID-19 pandemic.
INDEX TERMS Artificial Intelligence, COVID-19, Computer Vision, Review, Survey
I. INTRODUCTION
COVID-19, known as an infectious disease is caused by
severe acute respiratory syndrome (SARS-CoV-2) [1] and
named coronavirus due to its visual appearance (under an
electron microscope) to solar corona (similar to a crown)
[2]. The fight against COVID-19 has motivated researchers
worldwide to explore, understand, and devise new diagnostic
and treatment techniques to culminate this threat to our gen-
eration. In this article, we discuss how the computer vision
community is fighting with this menace by proposing new
types of approaches, improving efficiency, and speed of the
existing efforts.
The scientific response to combat COVID-19 has been far
quicker and widespread. A keyword search on PubMed and
the major open-access preprint repositories (arXiv, bioRxiv
and medRxiv) revealed that in 2019, 735 published papers
included the word “coronavirus”. FIGURE 1 illustrates our
findings. During the first half of 2020, this number has
increased a thirty-fold and rose to astounding 21,806 articles.
For comparison, the SARS pandemic, with less than 10,000
confirmed infections and <1,000 deaths, led roughly to a
four-fold increase over two years (2002: 221 and 2004: 822).
After the occurrence of MERS in 2012 (less than 3,000
confirmed infections and 1,000 deaths to date) a doubling in
coronavirus related papers over four years (2011 to 2015) was
observed.
The Economist has dubbed the current Herculean task
science of the times with the hope that such efforts would
help speed up the development of a COVID-19 vaccine [3].
Numerous approaches in computer vision have been pro-
posed so far, dealing with different aspects of combat the
COVID-19 pandemic. These approaches vary in terms of
their approach to the fundamental questions:
• How can medical imaging facilitate faster and reliable
diagnosis of COVID-19?
• Which image features correctly classify conditions as
Bacterial, Viral, COVID-19, and Pneumonia?
• What can we learn from imaging data acquired from
disease survivors to screen critical and non-critical ill
patients?
• How can computer vision be used to enforce social
distancing and early screening of infected people?
• How can 3D computer vision help to maintain health-
care equipment supply and guide the development of a
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FIGURE 1. A portrayal of current increase in research articles about coronavirus related research. Since their discovery in the early 1960s, coronavirus research
has increased substantially; especially after the SARS outbreak in 2002 made clear their pandemic potential. Previously, the most productive full year was 2004 with
822 coronavirus papers. The SARS-CoV-2 pandemic has caused a leap, with 21,806 articles only in the first half of 2020 (reference date for the analysis was 30
June 2020). Note that the y-axis is displayed in log-scale for visual clarity and that the height of the coloured bars shows their relative contribution.
COVID-19 vaccine?
The answers to these questions are being explored, and
preliminary work has been done.
The contribution of this review article is as follows:
This review paper classifies COVID-related computer vision
methods into broad categories and provides salient descrip-
tions of representative methods in each group. We aspire to
give readers the ability to understand the baseline efforts and
kickstart their work where others have left. Furthermore, we
aim to highlight new trends and innovative ideas to build a
more robust and well-planned strategy during this war of our
times.
Our survey will also include research articles in pre-print
format due to the time urgency imposed by this disease.
However, one limitation of this review is the inclusion of
the risk of lower quality and work without due validation.
Many of the works have not been put into the clinical trial
as it is time-consuming. Nevertheless, our intention here is
to share ideas from a single platform while highlighting the
computer vision community efforts. We hope that our reader
is aware of these contemporary challenges. This paper is an
extended and revised version of the earlier preprint survey
[4]. We follow a top-down approach to describe the research
problems that require urgent attention. We start with disease
diagnosis, discuss disease prevention and control, followed
by treatment-related computer vision research work.
We have organised the paper as follow: Section 2 describes
the overall taxonomy of computer vision research areas by
classifying these efforts into three classes. Section 3 provides
a detailed description of each research area, relevant papers,
and a brief description of representative work. Section 4
describes available resources, including research datasets,
their links, deep learning models, and codes. Section 5 pro-
vides the discussion and future work directions followed by
concluding remarks and references.
II. HISTORICAL DEVELOPMENT
The novel coronavirus SARS-CoV-2 is the seventh member
of the Corona viridae family of viruses which are enveloped,
non-segmented, positive-sense RNA viruses [5]. The mortal-
ity rate of COVID-19 is less than that of the severe acute
respiratory syndrome (SARS) and Middle East respiratory
syndrome (MERS) coronavirus diseases (10% for SARS-
CoV and 37% for MERS-CoV). However, it is highly infec-
tious, and the number of cases is on continuous rise [6].
The disease outbreak first reported in Wuhan, the Hubei
province of China, after several cases of pneumonia with
unknown causes were reported on 31 December 2019. A
novel coronavirus was discovered as the causative organism
through in-depth sequencing analysis of samples of patient’s
respiratory tract at Chinese facilities on 7 January 2020 [6].
The outbreak was announced as a Public Health Emergency
of International Concern on 30 January 2020. On 11 February
2020, the World Health Organization (WHO) announced a
name for the new coronavirus disease: COVID-19. It was
officially being considered pandemic after the 11 March
announcement by WHO [7].
III. TAXONOMY OF KEY AREAS OF RESEARCH
In this section, we describe the classification of computer
vision techniques that try to counter the menace of COVID-
19. For better comprehensibility, we have classified them into
three key areas of research: (i) diagnosis and prognosis, (ii)
disease prevention and control, and (iii) disease treatment
and management. FIGURE 2 shows this taxonomy. In the
following subsections, we discuss the research fields, the
relevant papers, and present a brief representative description
of related works.
A. DIAGNOSIS AND PROGNOSIS
An essential step in this fight is the reliable, faster, and af-
fordable diagnostic process that can be readily accessible and
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FIGURE 2. Classification of Computer Vision Approaches for COVID-19 Control. Our survey classifies COVID-19 related computer vision methods into three broad
categories.
available to the global community. According to Cambridge
dictionary [8], diagnosis is: ” the making of a judgment about
the exact character of a disease or other problem, especially
after an examination, or such a judgment" and prognosis is "a
doctor’s judgment of the likely or expected development of a
disease or of the chances of getting better".
Currently, Reverse transcriptase quantitative polymerase
chain reaction (RT-qPCR) tests are considered as the gold
standard for diagnosing COVID-19 [9]. During such a test,
small amounts of viral RNA are extracted from a nasal swab,
amplified, quantified. Virus detection is then performed us-
ing a fluorescent dye. Although accurate, the test is time-
consuming, manual and requires biomolecular testing facil-
ities which limits its availability in large scales and third-
world countries. Care has to be taken in interpreting negative
test results. A meta-study estimated the sensitivity over the
disease process and found a maximal sensitivity of 80%,
eight days after infection [10]. Some studies have also shown
false-positive PCR testing [11].
Computed Tomography (CT) Scan
An alternative approach is the use of a radiology examination
that uses computed tomography (CT) imaging [12]. A chest
CT scan is a non-invasive test conducted to obtain a precise
image of a patient’s chest. It uses an enhanced form of X-Ray
technology, providing more detailed images of the chest than
a standard X-Ray. It produces images that include bones, fats,
muscles, and organs, giving physicians a better view, which
is crucial when making accurate diagnoses.
A Chest CT scan is of two types: namely high-resolution
and spiral chest CT scan [13]. The high-resolution chest CT
scan provides more than a slice (or image) in a single rotation
of the X-Ray tube. The spiral chest CT scan application
involves a table that continuously moves through a tunnel-
like hole while the X-Ray tube follows a spiral path. The
advantage of the spiral CT is that it is capable of producing a
three-dimensional image of the lungs.
Important CT features include ground-glass opacity, con-
solidation, reticulation/thickened interlobular septa, nodules,
and lesion distribution (left, right or bilateral lungs) [14]
[15] [16] [17]. The most observable CT features discovered
in COVID-19 pneumonia include bilateral and sub pleural
areas of ground-glass opacification, consolidation affecting
the lower lobes. Within the intermediate stage (4-14 days
from symptom onset), crazy-paving pattern and possibly
observable Halo sign become important features as well [14]
[11] [12] [6] [12] [15] [16] [17] [18]. One case of CT images
is shown in FIGURE 3 that illustrates ground glass opacities
and ground halo features. As the identification of disease
features is time-consuming, even for expert radiologists,
computer vision can help by automating such a process.
Representative Work, Evaluation And Discussion
To date, various CT-scanning automated approaches have
been proposed [8] [12] [13] [14] [15] [16] [18] [19] [20] [21]
[22] [23] [24] [25] [26] [27]. To discuss the approach and
performance of the computer vision CT-based disease diag-
nosis, we have selected some recent representative works that
provide an overview of their effectiveness. It is worth noting
that they have been presenting different performance metrics
and using a diverse number of images and datasets. These
practices make their comparison very challenging. Some of
the metrics include Accuracy, Specificity, Sensitivity, Posi-
tive predictive value (PPV), Negative predictive value (NPV),
Area Under Curve (AUC), and F1 score. A quick elucidation
on their definition can be useful. The accuracy of a method
finds how correct the values are predicted. The precision finds
the reproducibility of the measurement; Recall presents how
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FIGURE 3. CT images adapted from [6] , [18] portray CT features related to COVID-19. Ground glass opacities (top) and ground glass halo (bottom).
many of the correct results are discovered while F1-score
uses a combination of precision and recall for a balanced
average result.
The first class of work discussed here approaches diag-
nosis as a segmentation problem. Jun Chen et al. [22] has
proposed a CT image dataset of 46,096 images of both
healthy and infected patients, labelled by expert radiologists.
It was collected from 106 patients admitted with 51 con-
firmed COVID-19 pneumonia and 55 control patients. The
work used deep learning models for segmentation only so
that it could identify the infected area in CT images between
healthy and infected patients. It was based on UNet++ se-
mantic segmentation model [23], used to extract valid areas
in the images. It used 289 randomly selected CT images and
tested it on other 600 randomly selected CT images. The
model achieved a per-patient sensitivity of 100%, specificity
of 93.55%, the accuracy of 95.24%, PPV (positive prediction
value) of 84.62%, and NPV (negative prediction value) of
100%. In the retrospective dataset, it resulted in a per-image
sensitivity of 94.34%, the specificity of 99.16%, the accuracy
of 98.85%, PPV of 88.37%, and NPV of 99.61%. The trained
model from this study was deployed at the Renmin Hospital
of Wuhan University (Wuhan, Hubei province, China) to
accelerate the diagnosis of new COVID-19 cases. It was
also open-sourced on the Internet to enable a rapid review
of new cases in other locations. A cloud-based open-access
artificial intelligence platform was constructed to provide
support for detecting COVID-19 pneumonia worldwide. For
this purpose, a website has been made available to provide
free access to the present model at (http://121.40.75.149/
znyx-ncov/index). TABLE 1 presents a description of the
representative techniques for CT based COVID-19 diagnosis.
The second type of work considered COVID-19 as a bi-
nary classification problem. Lin Li [24] proposed (COVNet),
to extract visual features from volumetric chest CT using
transfer learning on the RESNET50. Lung segmentation was
performed as a pre-processing task using the U-Net model.
It used 4356 chest CT exams from 3,322 patients from the
dataset collected from 6 hospitals between August 2016 and
February 2020. The sensitivity and specificity for COVID-19
are 90% (114 of 127; p-value<0.001) with 95% confidence
interval (CI) of [95% CI: 83%, 94%] and 96% (294 of
307; p-value<0.001) with [95% CI: 93%, 98%], respectively.
The model was also made available online for public use at
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TABLE 1. Representative Works For CT Based COVID-19 Diagnosis
Study Classification Model
and availability
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TABLE 1 Continued from previous page
Study Classification Model
and availability
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The diagnosis problem was also approached as a 3-
category classification task: distinguishing healthy patients
from those with other types of pneumonia and those with
COVID-19. Song et al. [24] used data from 88 patients
diagnosed with the COVID-19, 101 patients infected with
bacteria pneumonia, and 86 healthy individuals. It proposed
the DRE-Net (Relation Extraction neural network) based on
ResNet50, on which the Feature Pyramid Network (FPN)
[25] and the Attention module was integrated to represent
more fine-grained aspects of the images. An online server
is available for online diagnoses with CT images at http:
//biomed.nsccgz.cn/server/Ncov2019.
A recent landmark study was published by Mei et al. [27]
in Nature Medicine. In a cohort of 906 RT-PCR tested pa-
tients (419 COVID-positive), a two-stage CNN was com-
bined with an MLP on clinical features (age, sex, exposure
history, symptoms) and the diagnostic performance was com-
pared to senior radiologists. A “slice selection CNN” was
used to select abnormal CT scans which were subsequently
classified by the “disease diagnosis CNN”. Interestingly,
fusing a 512-dimensional vector of the CT scans with clinical
features yielded a joint model that significantly outperformed
the CNN-only model in ROC-AUC and specificity. On a
test set of 279 patients, the joint model surpassed senior
radiologists in ROC-AUC (0.92 vs. 0.84), while showing
worse specificity (83% vs. 94%) and statistically insignificant
better sensitivity (84% vs. 75%). The model also correctly
identified 68% of positive patients who exhibited normal CT
scans according to the radiologists. It hints toward the po-
tential of deep learning to pick-up complex, disease-relevant
patterns that may stay indiscernible for radiologists.
Due to limited time available for annotations and labelling,
weakly-supervised deep learning-based approaches have also
been developed using 3D CT volumes to detect COVID-
19. Chuansheng Zheng [26] proposed 3D deep convolutional
neural Network (DeCoVNet) to Detect COVID-19 from CT
volumes. The weakly supervised deep learning model could
accurately predict the COVID-19 infectious probability in
chest CT volumes without the need for annotating the lesions
for training. The CT images were segmented using a pre-
trained UNet. It used 499 CT volumes for training, collected
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from 13 December 2019 to 23 January 2020, and 131 CT
volumes for testing, collected from 24 January 2020 to 6
February 2020. The authors chose a probability threshold of
0.5 to classify COVID- positive and COVID- negative cases.
The algorithm obtained an accuracy of 0.901, a positive
predictive value of 0.840, and a high negative predictive value
of 0.982. The developed deep learning model is available at
https://github.com/sydney0zq/covid-19-detection.
X-Ray Imagery
One drawback of using CT imaging is the need for high
patient dose and enhanced cost [43]. The low availability
imposes Additional challenges for CT in remote areas and
the need of patient relocation and exhaustive disinfection of
the scanner rooms (several hours per day) that risk contagion
for staff and other patients [44]. These disadvantages call into
play chest X-Ray radiography (CXR) as a preferred first-line
imaging modality with lower cost and a wider availability for
detecting chest pathology. Digital X-Ray imagery computer-
aided diagnosis is used for different diseases, including os-
teoporosis [45], cancer [46] and cardiac disease [47]. How-
ever, as it is really hard to distinguish soft tissue with a poor
contrast in X-Ray imagery, contrast enhancement is used as
pre-processing step [48] [49] . Lung segmentation of chest X-
Rays is a crucial and important step in order to identify lung
nodules and various segmentation approaches are proposed
in the literature [50] [51] [52] [53].
CXR examinations show consolidation in COVID-19 in-
fected patients. In one study at Hong Kong [41], three differ-
ent patients had daily CXR, two of them showed progression
in the lung consolidation over 3-4 days. Further CXR exam-
inations show improvement over the subsequent two days.
The third patient showed no significant variations over eight
days. However, a similar study showed that the ground glass
opacities in the right lower lobe periphery on the CT are
not visible on the chest radiograph, which was taken 1 hour
apart from the first study. FIGURE 4 illustrates a scenario
with three chest XR chosen out of the daily chest CXR for a
patient. The consolidation can be observed in the CSR image.
In a large-scale study of 636 ambulatory COVID-19 patients,
Weinstock et al. found that 58% of CXR was normal and 89%
were normal or mildly abnormal [54]. Interstitial changes
(24%) and GGOs (19%) were the most prominent symptoms,
and abnormalities were most prevalent in the lower lobe
(34%). While the sensitivity of CXR is significantly lower
than for CT, the American College of Radiology (ACR)
recommends to conduct CXR with portable devices and only
if “medically necessary” for better radiological analysis. It
moreover firmly advises to not use any imaging technique
for COVID-19 diagnosis but instead suggests biomolecular
tests [55]. In the realm of AI,
Various CXR-related automated approaches are proposed.
The following section discusses the most salient work, while
TABLE 2 presents a more systematic presentation of such
methods.
Representative Work, Evaluation And Discussion
To date, many deep learning-based computer vision models
for X-Ray COVID-19 were proposed. One of the most signif-
icant development is the model COVID-Net [59] proposed
by Darwin AI, Canada. In this work, human-driven princi-
pled network design prototyping is combined with machine-
driven design exploration to produce a network architecture
for the detection of COVID-19 cases from chest X-Ray.
The first stage of the human-machine collaborative design
strategy is based on residual architecture design principles.
The dataset used to train and evaluate COVID-Net is referred
to as COVIDx [59] and comprise a total of 16,756 chest ra-
diography images across 13,645 patient cases. The proposed
model achieved 92.4% accuracy 80% sensitivity for COVID-
19 diagnosis.
The initial network design prototype makes one of three
classes: a) no infection (normal), b) non-COVID19 infection
(viral and bacterial), and c) COVID-19 viral infection. The
goal is to aid clinicians to decide better which treatment
strategy to employ depending on the cause of infection since
COVID-19 and non-COVID19 infections require different
treatment plans. In the second stage, data, along with human-
specific design requirements, act as a guide to a design explo-
ration strategy to learn and identify the optimal macro- and
microarchitecture designs to construct the final tailor-made
deep neural network architecture. The proposed COVIDNet
network diagram is shown in FIGURE 5 and available pub-
licly at https://github.com/lindawangg/COVID-Net.
Ezz El-Din Hemdan et al. [60] proposed the COVIDX-Net
based on seven different architectures of DCNNs; namely
VGG19, DenseNet201 [61] , InceptionV3, ResNetV2, In-
ceptionResNetV2, Xception, and MobileNetV2 [62]. These
models were trained on COVID-19 cases provided by Dr
Joseph Cohen and Dr Adrian Rosebrock, available at https://
github.com/ieee8023/covid-chestxray-dataset [63]. The best
model combination resulted in F1-scores of 0.89 and 0.91
for normal and COVID-19 cases. Similarly, Asmaa Abbas
et al. [64] proposed a Decompose, Transfer, and Compose
(DeTraC) approach for the classification of COVID-19 chest
X-Ray images. The authors applied CNN features of pre-
trained models on ImageNet and ResNet to perform the
diagnoses. The dataset consisted of 80 samples of normal
CXRs (with 4020 x 4892 pixels) from the Japanese Society of
Radiological Technology (JSRT) Cohen JP. COVID-19 im-
age data collection, available at https://githubcom/ieee8023/
covid-chestxray-dataset [63]. This model achieved an accu-
racy of 95.12% (with a sensitivity of 97.91%, a specificity of
91.87%, and a precision of 93.36%). The code is available at
https://github.com/asmaa4may/DeTraCCOVId19.
Biraja Ghoshal et al. . [58] introduced Uncertainty-Aware
COVID-19 Classification and Referral model with the pro-
posed Dropweights based on Bayesian Convolutional Neural
Networks (BCNN). For COVID-19 detection to be meaning-
ful, two types of predictive uncertainty in deep learning were
used on a subsequent work [65] . One of it is Epistemic,
or Model uncertainty accounts for the model parameters
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FIGURE 4. Chest CXR of an elderly male patient ( Wuhan, China, who travelled to Hong Kong, China). Provided are three chest XR chosen out of the daily chest
CXR for this patient. The consolidation can be observed in the right lower zone on day 0 persist into day four, followed by novel consolidate changes in the right
mid-zone periphery and perihelia region. Such type of mid-zone change improved on the day seven-film. Image adapted from [41].
FIGURE 5. Architectural diagram of COVID-Net [42]. We can observe High architectural diversity and selective long-range connectivity.
uncertainty as it does not take all of the aspects of the
data into account or the lack of training data. The other is
Aleatoric uncertainty that accounts for noise inherent in the
observations due to class overlap, label noise, homoscedastic
and heteroscedastic noise, which cannot be reduced even if
more data were to be collected. Bayesian Active Learning by
Disagreement (BALD) [66], is based on mutual information
that maximizes the information between model posterior and
predictions density functions approximated as the difference
between the entropy of the predictive distribution and the
mean entropy of predictions across samples.
A BCCN model was trained on 68 Posterior-Anterior
(PA) X-Ray images of lungs with COVID-19 cases from
Dr Joseph Cohen’s Github repository [63], augmented the
dataset with Kaggle’s Chest X-Ray Images (Pneumonia)
from healthy patients. It achieved 88.39% accuracy on the
available dataset. This work additionally recommended visu-
alisation of distinct features, as an additional insight to point
prediction for a more informed decision-making process. It
used the saliency maps produced by various state-of-the-art
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FIGURE 6. Detection of COVID-19 from ultrasound images: Ultrasound imagery is widely available and accessible throughout the world and therefore, can be a
valuable tool for monitoring disease progression. Adapted from [56].
FIGURE 7. Temperature screening in process with thermal imagery of a subject who is talking on a mobile phone; (a) after 1 min of talking and (b) after 15 min of
talking. It shows that the temperature of the encircled region increased from 30.56 to 35.15 C after 15 min of talking. The temperature of the region around the ear
(indicated by an arrow) elevated from 33.35 to 34.82C. A similar system can be used for COVID-19 related fever screening.Adapted from [57].
methods, e.g. Class Activation Map (CAM) [67], Guided
Backpropagation, and Guided Gradient, and Gradients to
show more distinct features in the CSR images.
A Capsule Network-based Framework called COVID-
CAPS [68] is proposed for the Identification of COVID-
19 cases from X-ray Images. A lightweight deep neu-
ral network (DNN) based mobile app is proposed in [69]
that can process noisy images of chest X-ray (CXR)
for point-of-care COVID-19 screening and is available at
url:https://github.com/xinli0928/COVID-Xray. A 3-step ap-
proach to fine-tune a pre-trained ResNet-50 architecture to
improve model performance is proposed by [70]. Similar
other works are proposed recently [71]–[73].
To the best of our knowledge, [74] reported the largest
dataset including 144,167 images from 750 patients (400
COVID patients). As deep-learning models are data-hungry
and most other projects perform transfer learning on ex-
tremely small datasets (often < 1000 images), this is a
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FIGURE 8. Visualizations shown by using different saliency maps that provide additional insights diagnosis. These maps help to identify the areas of activation that
can lead to disease progression monitoring and severity detection. Adapted from [58].
remarkable project and a first step towards signifying more
realistic and clinically relevant performance estimates. The
classifier achieves a sensitivity of 95% and a specificity of
93%. Besides, a segmentation model is trained with the deep
supervision strategy and shown to identify lesion areas of the
positive predictions. One drawback of the work is that the
models operate autonomously and the lesions identified by
the segmentation model may by no means have been relevant
for the positive prediction of the classifier.
Ultrasound Imaging
Lung ultrasound (LUS) is evolved over the last few years to
its theoretical and operative aspects. One of the characteristic
features of LUS is its ability to define the alterations affecting
the ratio between tissue and air in the superficial lung [56],
[80].
The practical advantages of LUS are numerous: US de-
vices are portable, bringing along the salient benefit of per-
forming a point-of-care LUS at the patient’s bedside or even
home that can easily be repeated for monitoring purposes.
LUS minimizes the requirement for transferring the patient,
controlling the potential risk of further infection and spread-
ing it among health care personnel.
In contrast to CT and X-Ray, US is non-irradiating, and
the instruments are cheap and thus highly available even
outside developed countries [81]. However, ultrasound is
operator-dependent and to follow standardized protocols for
LUS like the BLUE protocol [82], experienced technicians
are desired. This is boon and bane: While conducting a full
LUS can take a few minutes and cause significantly higher
portions of data than other modalities, the auto-correlation is
exceptionally high and diagnostic patterns are visible only in
few frames. LUS was repeatedly shown superiority to CXR
for diagnosing pulmonary diseases (for review see [83]),
especially in resource-limited settings [84]. For COVID-19,
LUS patterns are correlated to disease stage, comorbidities
and severity of pulmonary injury [85] and most dominantly
include B-lines, vertical artifacts that range from the pleural
deep into the lung [86]. Importantly, LUS was lately reported
higher sensitivity and equal specificity than CXR in diag-
nosing COVID-19 [87]. In a comparison of LUS to CT, it
was shown that for all typical features of LUS in COVID-
19 patients, analogs to known patterns in CT scans could be
found [88]. FIGURE 6 illustrates the detection of COVID-
19 from ultrasound images. While LUS is used commonly
as a first-line examination method in European countries like
Italy [89], it is not mentioned in the ACR recommendations
as clinical practice for COVID [55]. Besides, some articles
argued that LUS can assist early diagnosis and assessment of
COVID and even found better sensitivity of LUS in detecting
certain features [90]. This has caused a vivid debate on the
role of LUS for the COVID pandemic [91]–[94].
Representative Work, Evaluation And Discussion
Since LUS is a less established practice for examining
COVID-19 patients, less clinical data is recorded and pub-
licly available. It is presumably a primary reason why fewer
computer vision projects focus on it, despite the advocacy of
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TABLE 2. Representative Work for X-Ray Based COVID-19 Diagnosis
Study Model Dataset Performance
Guszt’av Ga’al et al.
[53]
Attention U-Net+ adversarial+ Contrast
Limited Adaptive Histogram Equalization
(CLAHE) [75]
247 images from Japanese Society of Ra-
diological Technology (JSRT) Dataset+
Shenzhen dataset contains a total of 662
chest X-Rays
DSC of 97.5% on the JSRT
dataset
Asmaa Abbas et al.
[64]
CNN features of pre-trained models on
ImageNet and ResNet+ Decompose,
Transfer, and Compose (DeTraC),
for the classification of COVID-19
chest X-Ray images: The developed
code is available at https://github.com/
asmaa4may/DeTraCCOVId19
I80 samples of normal CXRs (with
4020 x 4892 pixels) from the Japanese
Society of Radiological Technology
(JSRT) + Cohen JP. COVID-19 image data
collection. https://githubcom/ieee8023/
covid-chestxray-dataset.2020;.
High accuracy of 95.12%
(with a sensitivity of 97.91%,
a specificity of 91.87%, and a
precision of 93.36%)
Ali Narin et al. [76] Pre-trained ResNet50 model with transfer
learning
The open source GitHub repository
shared by Dr. Joseph Cohen+Chest




for InceptionV3 and 87%
accuracy for Inception-
ResNetV2).
Linda Wang et al. [42] COVID-Net: lightweight residual pro-
jection expansion- projection-extension
(PEPX) design pattern, Model is available
publicly for open access at https://github.
com/lindawangg/COVID-Net.
COVIDx dataset: 16,756 chest radiogra-
phy images across 13,645 patient cases
from two open access data repositories
Accuracy 92.4% on COVIDx
dataset
Ezz El-Din Hemdan et
al. [60]
COVIDX-Net: based on seven different
architectures of DCNNs; namely VGG19,
DenseNet201, InceptionV3, ResNetV2,
Inception ResNetV2, Xception, and Mo-
bileNetV2
COVID-19 cases provided by Dr. Joseph
Cohen and Dr. Adrian Rosebrock [63]
F1-scores of 89% and 91%















Prabira Kumar Sethy et
al. [78]
Deep features from Resnet50 + SVM clas-
sification
Data available in the repository of GitHub,
Kaggle and Open-i as per their validated
X-Ray images.
Resnet50 plus SVM achieved
accuracy, FPR, F1 score,






Various fine-tune dmodels: VGG19, Mo-
bileNet, Inception,Inception Resnet V2,
Xception
1427 X-Ray images. 224 images with con-
firmed Covid-19, 700 images with con-
firmed common pneumonia, and 504 im-
ages of normal conditions are included
Accuracy with Xception was
the highest, 95.57%, sensitiv-
ity of 8% and specificity of
99.99%.
Biraja Ghoshal et al.
[58]
Dropweights based Bayesian Convolu-
tional Neural Networks (BCNN)
68 Posterior-Anterior (PA) X-Ray images
of lungs with COVID-19 cases from Dr.
Joseph Cohen’s Github repository, aug-
mented the dataset with Kaggle’s Chest X-
Ray Images (Pneumonia) from healthy pa-
tients, a total of 5941 PA chest radiography
images across 4 classes (Normal: 1583,
Bacterial Pneumonia: 2786, non-COVID-
19 Viral Pneumonia: 1504, and COVID-
19: 68).





3-step technique to fine-tune a pre-trained
ResNet-50 architecture to improve model
performance
COVIDx dataset Accuracy of 96.23% (on all
the classes) on the COVIDx
dataset
Yu-Huan Wu et al. [74] 3-class classifier (healthy, COVID-19,
non-COVID-pneumonia with Res2Net
backbone. Segmenation model wih
VGG-16 backbone
COVID-CS dataset (144,167 images, 750
patients of which are 400 COVID-19 posi-
tive)
95% sensitivity and 93%
specificity
recent trends in medicine (see above).. TABLE 3 presents a
more categorical presentation of such methods.
Preliminary investigations for clarifying the diagnostic
and prognostic role of LUS in COVID-19 are underway.
Computer vision on ultrasound imaging became increasingly
popular in the last years [95], but comparably little work has
been done on LUS.
The first work to apply computer vision on ultrasound
probes of COVID-19 patients was POCOVID-Net, a deep
convolutional neural network with a VGG backbone [96].
POCOVID-Net introduced an LUS dataset that initially
consisted of 1103 images (654 COVID-19, 277 bacterial
pneumonia, and 172 healthy controls), sampled from 64
videos. As of July 2020, the dataset contains ∼150 videos
and ∼50 images, resembling the largest publicly avail-
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able dataset of LUS: https://github.com/jannisborn/covid19_
pocus_ultrasound. Besides, the trained models were de-
ployed and can be freely used at: https://pocovidscreen.org.
On the initial dataset, POCOVID-Net reports a video accu-
racy of 92% and a sensitivity and specificity of 96% and
79% for COVID-19 respectively. It accounts for a prelim-
inary proof-of-concept that COVID-19 can be automatically
distinguished from other pulmonary conditions through LUS,
and it opens a branch to follow up on the granularity of the
differentiation.
On the updated POCOVID-Net dataset, performance could
be improved with an accuracy of 94%, sensitivity and speci-
ficity of 98% and 91% in a 5-fold cross-validation on LUS
videos [97]. This work utilizes Bayesian deep learning to
compute uncertainty estimations that are deemed crucial for
medical imaging [98]. [97] then demonstrated how epistemic
uncertainty estimations (measured by Monte Carlo dropout)
could let the model self-recognize low confidence situations.
Additionally, the authors computed and validated CAMs
with the help of medical experts and found that the model
learns in a completely unsupervised fashion to highlight lung
consolidations (94% sensitivity) and, to a lesser extent, A-
lines (62%).
The CAMs were overall found helpful for diagnosis by
the experts. However, it leaves room for improvement in
B-line detection. Interestingly, the performance could be
mildly improved when the classifier was coupled with the
segmentation model by [99].
The named work by [99] introduced a rich stack of CNN
models for segmentation and severity assessment of COVID-
19 patients. Based on ∼1000 images from convex probes of
33 patients, an ensemble of 3 segmentation models (UNet,
UNet++ and Deeplabv3+) is shown to reliable extract both,
A-lines and COVID biomarkers (accuracy 96%, binary dice
score 0.75). Besides, they classify COVID severity on four
levels (0 to 3). They introduce a so-called regularised spa-
tial transformer network that performs a weak localization
by extracting two transformed image sections that, ideally,
should contain pathological artifacts. Their model achieves
a precision of 70% and a recall of 60% on the four-class
classification. However, despite the authors claim to release
a dataset of 277 LUS videos from 35 patients with a total
of almost 60,000 frames, to date, only 60 videos can be
accessed (after the account request is manually approval).
No annotations are available for those videos, rendering a
validation of the results effectively impossible.
As B-lines are maybe the most critical LUS feature in
COVID patients, [100] presented a specialized approach
for line artifact quantification that utilizes a non-convex
regularization technique dubbed Cauchy proximal splitting.
This technique outperforms state-of-the-art B-line identifi-
cation [101] and detects 87% of the B-lines in 9 COVID-
19 patients, reducing the error margin by 40% compared
to [101].
Since ultrasound equipment is small and portable op-
tions are available (POCUS devices), the impact of web-
independent, on-device analysis is high, especially since LUS
belongs to the standard repertoire even in remote medical
facilities.
Future projects could, for example, improve the mediocre
results found in an ablation study with mobile-friendly
CNNs [97] to facilitate on-device processing.
B. PREVENTION AND CONTROL
WHO has provided some guidelines on infection prevention
and control (IPC) strategies for use when infection with
a novel coronavirus is suspected [106]. Major IPC tries
to control transmission in health care settings that include
early recognition and source control and applying standard
precautions for all patients. It also includes implementation
of additional empiric precautions like airborne precautions
for suspected cases of COVID-19, implementation of admin-
istrative controls, and use of environmental and engineering
controls. Computer vision applications are providing valu-
able support for the implementation of IPC strategies.
Representative Work, Evaluation and Discussion
Protective techniques to control the virus spread in the early
stage of disease progression were considered very early, as
the usage of masks. Some countries like China implemented
it as a control strategy at the start of the epidemic. Computer
vision-based systems greatly facilitated such implementa-
tion.
Zhongyuan Wang et al. . [102] proposed the Masked Face
Recognition approach using a multi granularity masked face
recognition model, resulting in 95% accuracy on a masked
face image dataset. The data was made public for research
and provided three types of masked face datasets, including
Masked Face Detection Dataset (MFDD), [107], Real-world
Masked Face Recognition Dataset (RMFRD) and Simulated
Masked Face Recognition Dataset (SMFRD) [108].
A similar strategy is the use of Infrared thermography.
It can be used as an early detection strategy for infected
people, especially in crowns like passengers at an airport-
various medical applications of infrared thermography re
summarised by B.B. Lahiri [57], including fever screening.
Somboonkaew et al. [109] introduced a mobile platform that
can be used for an automatic fever screening system using
forehead temperature. Ghassemi et al. [110] has discussed
the best practices for standardized performance and testing
of infrared thermographs. An Infection Screening System
based on Thermography and CCD Camera is proposed by
Negishi et al. [111] with Good Stability and Swiftness for
Non-contact Vital-Signs Measurement by Feature Matching
and MUSIC Algorithm. Earlier for SARD spread control. A
computer vision system to help in fever screening by Chiu
et al. [104] was used in earlier outbreaks of SARS. From 13
April to 12 May 2003, 72,327 patients and visitors passed
through the only entrance allowed at TMU-WFH where a
thermography station was in operation. FIGURE 7 illustrates
the use of thermal imagery for temperature screening.
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FIGURE 9. Method of Corona score calculation for patient disease progression monitoring is illustrated. It is one of the ways infected areas can be visualised, and
disease severity can be predicted for better disease management and patient care. [35].
TABLE 3. Representative Works For Infected Disease Prevention And Control
Study Prevention Control Methodology Implementation/ Dataset Performance
Zhongyuan Wang et al.
[102]
Masked Face Recognition based on deep
learning




face recognition model we de-
veloped achieves 95% accu-
racy
Joshua M. Pearce [103] RepRap-class 3-D printers and open
source microcontrollers, mass distributed
manufacturing of ventilators
3D printing can facilitate sup-
ply chain.
W. Chiu, et al. [104] Inrfrared thermograpgy : Mass-fever
screening
72,327 patients or visitors passed through
the only entrance where a thermography
station was in operation.
Over a period of one month,
hundred and five patients or
visitors were detected to have
a thermographic fever detec-
tion
Edouard A. Hay [105] Convolutional neural networks for
identification of bacteria: Github
repository https://github.com/rplab/
Bacterial-Identification.
Light sheet microscopy image data Over 90% accuracy
Additional miscellaneous approaches for prevention and
control are also worth noting. An example is pandemic
drones using remote sensing and digital imagery, which were
recommended for identifying infected people. Al-Naji et al.
[112] have used such a system for remote life sign monitoring
in disaster management in the past. A similar application is
to use vision-guided robot control for 3D object recognition
and manipulation. Moreover, 3D modelling and printers are
helping to maintain the supply of healthcare equipment in this
troubled time. Joshua M. Pearce [103] discusses RepRap-
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class 3-D printers and open-source microcontrollers. The ap-
plications are relevant since mass distributed manufacturing
of ventilators has the potential to overcome medical supply
shortages. Lastly, germ scanning is an essential step against
combating COVID-19. Edouard A. Hay [105] has proposed
a convolutional neural network for germ scanning such as the
identification of bacteria Light-sheet microscopy image data
with more than 90% accuracy.
C. TREATMENT AND CLINICAL MANAGEMENT
Although various attempts and claims of vaccinations de-
velopment are announced in the media, however, there is
no agreed and widely used treatment for disease caused by
the virus at the moment. However, many of the COVID-19
symptoms can be treated.depending on the clinical condi-
tion of the patient. An improvement in clinical management
practices is possible through automating various practices
with the help of computer vision. One example is the clas-
sification of patients based on the severity of the disease
and advising them appropriate medical care. FIGURE 8.
provides a scenario of progression and severity monitoring by
using different saliency maps that provide additional insights
diagnosis. These maps help to identify the areas of activation
that can lead to disease progression monitoring and severity
detection. FIGURE 9 illustrates the Corona score calculation
on a 3D model of patients CT images for patient disease
progression. It is one of the ways infected areas can be
visualised, and disease severity can be predicted for better
disease management and patient care. TABLE 4 presents a
more categorical presentation of such methods.
Representative Work, Evaluation And Discussion
An essential part of the fight against the virus is clinical
management, which can be done by identifying patients that
are critically ill so that they get immediate medical attention
or ventilator support. A disease progression score is recom-
mended to classify different types of infected patients in [35].
It is called “corona score” and is calculated by measurements
of infected areas and the severity of disease from CT images.
The corona score measures the progression of patients over
time, and it is computed by a volumetric summation of the
network-activation maps.
Graeme MacLaren [113] supports that radiological evi-
dence can also be an essential tool to distinguish critically
ill patients. Yunlu Wang [114] used depth camera and deep
learning as abnormal respiratory patterns classifier that may
contribute to the large-scale screening of people infected with
the virus accurately and unobtrusively. Respiratory Simula-
tion Model (RSM) is developed to control the gap between
scarce real-world data and a large amount of training data.
They proposed GRU neural network with bidirectional and
attentional mechanisms (BI-AT-GRU) to classify six clin-
ically significant respiratory patterns (Eupnea, Tachypnea,
Bradypnea, Biots, Cheyne-Stokes, and Central-Apnea) to
identify critically ill patients. The proposed model can clas-
sify the respiratory patterns with accuracy, precision, recall,
and F1 of 94.5%, 94.4%, 95.1%, and 94.8%, respectively.
Demo videos of this method working in situations of one
subject and two subjects can be accessed online (https://doi.
org/10.6084/m9.figshare.11493666.v1).
The CoV spike (S) glycoprotein is the main target for vac-
cines, therapeutic antibodies, and diagnostics that can guide
future decisions. The virus connects to host cells through its
trimeric spike glycoprotein. Using biophysical assays, Daniel
Wrapp et al. [115] illustrated that this protein binds to their
common host cell receptor at least ten times more tightly than
the corresponding spike protein of severe acute respiratory
syndrome (SARS)-CoV. Protein X-ray crystallography can
discover the atomic structure of molecules and their func-
tions. It can further facilitate scientists to design new drugs
targeted to that function. MAchine Recognition of Crystal-
lization Outcomes (MARCO) [116] initiative has introduced
deep convolutional networks to achieve an accuracy of more
than 94% on the visual recognition task of identifying protein
crystals. It uncovers the potential of computer vision and
deep learning for drug discovery.
Quantitative structure-activity relationship (QSAR) analy-
sis has perspectives on drug discovery and toxicology [117].
It employs structural, quantum chemical and physicochemi-
cal features calculated from molecular geometry as explana-
tory variables predicting physiological activity. Deep fea-
ture representation learning can be used for QSAR analysis
by incorporating 360◦ images of molecular conformations.
Yoshihiro Uesaw [118] has proposed QSAR (Quantitative
structure-activity relationship) analysis using deep learning
using a novel molecular image input technique. Similar tech-
niques can be used for drug discovery to pave the way for
vaccine development for COVID-19.
IV. DATASET AND RESOURCES
CT IMAGES
• COVID-CT-Dataset [119] - The University of San
Diego has released a data set with 349 CT images
containing clinical findings of COVID-19. It claims to
be the largest of its kind. To demonstrate its potential,
an AI model is trained, achieving 85% accuracy. The
data set is available at https://github.com/UCSD-AI4H/
COVID-CT.
• An image-based model working with CTs for




• COVID-19 Radiography database [120] - A team of
researchers from Qatar University, Doha, and the Uni-
versity of Dhaka, Bangladesh, along with collabora-
tors from Pakistan and Malaysia with medical doc-
tors have created a database of chest X-Ray images
for COVID-19 positive cases along with Normal and
Viral Pneumonia images. In the current release, there
are 219 COVID-19 positive images, 1341 normal im-
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TABLE 4. Representative works for infected disease Treatment and Progression Monitoring
Study Treatment Or Management Methodology Implications
Daniel Wrapp et al. [115] Using biophysical assays, it is shown that this protein
binds at least 10 times more tightly than the correspond-
ing spike protein of severe acute respiratory syndrome
(SARS)-CoV to their common host cell receptor.
The virus connects to host cells through its trimeric
spike glycoprotein. 3.5-angstrom-resolution cryo-
electron microscopy structure of the 2019-nCoVS
trimer in the prefusion conformation was studied
These studies provide valuable. information to guide
the development of medical counter-measures for
2019-nCoV.
Ophir Gozes et al. [35] Corona score for patient disease progression monitoring
and screening
It was basedonthe development of CT images Dataset
provide d by ChainZ (www.ChainZ.cn) and Corona
score was used to screen critically ill patients. For
instance, Corona score of 191.5 cm3 was observed at
the time of Admission and after recovery, it turned 0
means no opacities
Yunlu Wang et. al. [114] Depth camera and deep learning is used to classify 6
clinically significant respiratory patterns. GRU neural
network with bidirectional and attentional mechanisms
(BI-AT-GRU)
Abnormal respiratory patterns classifier can be able to
large-scale screening of people infected with COVID-
19
Yoshihiro Uesawa et. al. [118] Quantitative structure-activity relationship analysis
with the help of deep learning
Potential use in Drug discovery
ages and 1345 viral pneumonia images. The authors
said that they would continue to update this database
as soon as new X-Ray images for COVID-19 pneu-
monia patients. The project can be found at GitHub
with MATLAB codes and trained models: https://github.
com/tawsifur/COVID-19-Chest-X-Ray-Detection. The
research team managed to classify COVID-19, Viral
pneumonia and Normal Chest X-Ray images with an
accuracy of 98.3%. This scholarly work was submitted
to Scientific Reports (Nature), and the manuscript was
uploaded to ArXiv. Please make sure to give credit while
using the dataset, code and trained models.
• COVID-19 Image Data Collection [63]- An initial
COVID-19 open image data collection is provided by
Joseph Paul Cohen. all images and data are released
under the following URL https://github.com/ieee8023/
covid-chestxray-dataset.
• COVIDx Dataset [42] - This is the release of the
brand-new COVIDx dataset with 16,756 chest radiog-
raphy images across 13,645 patient cases. The current
COVIDx dataset is constructed by the open-source chest
radiography datasets at https://github.com/ieee8023/
covid-chestxray-dataset and https://www.kaggle.com/c/
rsna-pneumonia-detection-challenge. It is a combina-
tion of data provided by many parties: the Radiological
Society of North America (RSNA), others involved in
the RSNA Pneumonia Detection Challenge, Dr Joseph
Paul Cohen, and the team at MILA, involved in the
COVID-19 image data collection project for making
data available to the global community.
• Chest X-Ray8 [121] - The chest X-Ray is one of the
most commonly accessible radiological examinations
for screening and diagnosis of many lung diseases.
A tremendous number of X-Ray imaging studies ac-
companied by radiological reports are accumulated and
stored in many modern hospitals’ Picture Archiving
and Communication Systems (PACS), available at https:
//nihcc.app.box.com/v/ChestXray-NIHCC).
OTHER IMAGES
• Lung ultrasound dataset [96] - An open data collection
initiative similar of LUS, similar to the one by Cohen et
al. for CT and CXR. The growing database is continu-
ously updated and while it partially collects data from
dispersed public sources it also releases unpublished
clinical data. The dataset is thought to facilitate differen-
tial diagnosis from LUS and provides 4 classes (healthy,
bacterial pneumonia, COVID-19 and non-COVID viral
pneumonia. As of July 2020, the dataset contains ∼150
videos and ∼50 images resembling the largest publicly
available dataset of LUS: https://github.com/jannisborn/
covid19_pocus_ultrasound.
• Masked Face Recognition Datasets [102] - Three
types of masked face datasets were introduced, includ-
ing Masked Face Detection Dataset (MFDD), Real-
world Masked Face Recognition Dataset (RMFRD)
and Simulated Masked Face Recognition Dataset (SM-
FRD). MFDD dataset can be used to train an accu-
rate masked face detection model, which serves for
the subsequent masked face recognition task. RM-
FRD dataset includes 5,000 pictures of 525 people
wearing masks and 90,000 images of the same 525
subjects without masks. To the best of our knowl-
edge, this is currently the world’s largest real-world
masked face dataset. SMFRD is a simulated masked
face data set covering 500,000 face images of 10,000
subjects. These datasets are available at https://github.
com/X-zhangyang/Real-World-Masked-Face-Dataset.
• Thermal Images Datasets - There is no dataset
of thermals for high fever screening. However, a
fully annotated thermal face database and its ap-
plication for thermal facial expression recognition
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were proposed by Marcin Kopaczka [122]. Infor-
mation on further ideas of related data that can
be figured out by using such systems is avail-
able at http://www.flir.com.au/discover/public-safety/
thermal-imaging-for-detecting-elevated-body-temperature/.
V. DISCUSSION AND FUTURE WORK
Overall, it is encouraging that the computer vision research
community had a massive response in return to the call for
fighting COVID-19 epidemic. Data was collected and shared
in a short time, and researchers proposed various approaches
to address different challenges related to disease control.
It became possible due to recent success in the field of
deep learning and artificial intelligence. Web repositories like
GitHub and ArXiv have contributed significantly to the rapid
sharing of information. However, the impact of this research
work is limited due to lack of clinical testing, fair evaluation
and appropriate imaging datasets.
We argue that COVID-19 research landscape is quite broad
that covers more than imaging and becomes beyond the scope
of computer vision research. Similarly, we did not include
any machine learning or signal processing work that does
not include imaging modality. Most of the research work
is performed around disease diagnosis problem with various
performance metrics and without clinical trials that make it
hard to compare their performance.
Similarly, various research datasets have been released for
research purpose since the outbreak of the epidemic. How-
ever, these datasets can offer only limited scope and problem
domains. For instance, for disease progression, often mul-
tiple images related to single patients are required with the
timeline. Similarly, to evaluate different imaging modalities,
researchers require multimodal imaging data related to the
same patient that is not yet available for research purposes.
The future work includes the fair performance comparison
of different approaches, collection of a vast universal dataset
and benchmark. We hope that the collective efforts of com-
puter vision community like Imagaenet challenge can fill up
this gap.
VI. CONCLUDING REMARKS
In this article, we presented an extensive survey of com-
puter vision efforts and methods to combat the COVID-
19 pandemic challenge and also gave a brief review of
the representative work to date. We divide the described
methods into four categories based on their role in disease
control: Computed Tomography (CT) scans, X-Ray Imagery,
Ultrasound imaging and Prevention and Control. We provide
detailed summaries of preliminary representative work, in-
cluding available resources to facilitate further research and
development. We hope that, in this first survey on Computer
vision methods for COVID-19 control with extensive bibli-
ography content, one can find give valuable insight into this
domain and encourage new research. However, this work can
be considered only as an early review since many computer
vision approaches are being proposed and tested to control
the COVID-19 pandemic at the current time. We believe that
such efforts will be having a far-reaching impact with positive
results to periods during the outbreak and post the COVID-19
pandemic.
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